2011 Archive

SynCo Bio Partners Expands the Class A Zone in its Aseptic Filling Facility


Posted: 04/08/2011

Amsterdam, the Netherlands, August 4, 2011 - SynCo Bio Partners B.V., one of the leading GMP contract manufacturers of biopharmaceuticals today announced that its aseptic filling facility is again fully operational and SynCo has produced and released the first drug product batches for its clients after the expansion of the Class A zone. 

Read more

SynCo Bio Partners to Manufacture Syntaxin’s SXN101959 Novel Drug for Treatment of Acromegaly


Posted: 11/05/2011

Amsterdam, the Netherlands, May 11, 2011 - SynCo Bio Partners B.V., one of the leading GMP contract manufacturers of biopharmaceuticals, announced today that it has signed an agreement with Syntaxin to produce its novel drug candidate SXN101959.

Read more